Nifty
:
23587.50
Sensex
:
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)
Nifty
Sensex
:
:
23587.50
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)

Medicamen Biotech Ltd.

Pharmaceuticals & Drugs - Global

Rating :
N/A

BSE: 531146 | NSE: MEDICAMEQ

NSE BSE
522.60
20-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  553.00
  •  558.70
  •  513.60
  •  549.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  22890
  •  122.03
  •  630.00
  •  355.45

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 664.40
  • 95.39
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 678.15
  • 0.19%
  • 3.18

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 42.99%
  • 3.19%
  • 32.44%
  • FII
  • DII
  • Others
  • 0.06%
  • 0.00%
  • 21.32%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.28
  • 7.40
  • 15.81

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.38
  • 3.85
  • -0.48

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 40.62
  • -6.51
  • -13.96

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 57.60
  • 57.60
  • 59.53

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.95
  • 4.95
  • 4.87

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 33.53
  • 33.53
  • 34.05

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
44.74
43.54
2.76%
43.05
41.94
2.65%
47.32
38.66
22.40%
46.50
35.58
30.69%
Expenses
39.43
38.90
1.36%
39.60
34.99
13.18%
41.57
32.17
29.22%
41.61
29.71
40.05%
EBITDA
5.32
4.65
14.41%
3.45
6.95
-50.36%
5.75
6.49
-11.40%
4.89
5.88
-16.84%
EBIDTM
11.88%
10.67%
8.00%
16.57%
12.16%
16.79%
10.52%
16.51%
Other Income
0.29
0.55
-47.27%
0.59
0.38
55.26%
0.57
0.35
62.86%
0.83
0.63
31.75%
Interest
1.04
0.91
14.29%
0.71
0.96
-26.04%
1.89
0.86
119.77%
0.65
0.68
-4.41%
Depreciation
2.61
1.82
43.41%
1.77
1.69
4.73%
1.77
1.62
9.26%
1.81
1.60
13.12%
PBT
1.96
2.46
-20.33%
1.56
4.68
-66.67%
2.66
4.36
-38.99%
3.27
4.22
-22.51%
Tax
1.05
0.99
6.06%
0.76
0.74
2.70%
0.62
0.59
5.08%
1.24
0.45
175.56%
PAT
0.91
1.48
-38.51%
0.80
3.95
-79.75%
2.04
3.77
-45.89%
2.03
3.77
-46.15%
PATM
2.02%
3.39%
1.85%
9.41%
4.32%
9.75%
4.37%
10.60%
EPS
1.15
1.17
-1.71%
1.06
3.30
-67.88%
1.67
3.07
-45.60%
1.60
2.98
-46.31%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Net Sales
181.61
179.31
140.87
115.45
112.72
125.50
122.60
Net Sales Growth
13.71%
27.29%
22.02%
2.42%
-10.18%
2.37%
 
Cost Of Goods Sold
97.11
73.18
53.25
43.51
50.06
65.62
69.26
Gross Profit
84.50
106.13
87.62
71.93
62.65
59.89
53.34
GP Margin
46.53%
59.19%
62.20%
62.30%
55.58%
47.72%
43.51%
Total Expenditure
162.21
155.79
116.53
91.36
93.04
106.03
105.14
Power & Fuel Cost
-
7.14
5.67
5.86
2.68
2.90
2.11
% Of Sales
-
3.98%
4.02%
5.08%
2.38%
2.31%
1.72%
Employee Cost
-
29.07
20.15
14.50
9.00
9.52
8.09
% Of Sales
-
16.21%
14.30%
12.56%
7.98%
7.59%
6.60%
Manufacturing Exp.
-
29.33
27.14
18.12
26.48
21.99
19.85
% Of Sales
-
16.36%
19.27%
15.70%
23.49%
17.52%
16.19%
General & Admin Exp.
-
8.58
5.67
4.93
2.76
3.92
3.29
% Of Sales
-
4.79%
4.02%
4.27%
2.45%
3.12%
2.68%
Selling & Distn. Exp.
-
7.27
3.48
3.36
1.71
1.77
2.33
% Of Sales
-
4.05%
2.47%
2.91%
1.52%
1.41%
1.90%
Miscellaneous Exp.
-
1.23
1.18
1.07
0.34
0.32
0.22
% Of Sales
-
0.69%
0.84%
0.93%
0.30%
0.25%
0.18%
EBITDA
19.41
23.52
24.34
24.09
19.68
19.47
17.46
EBITDA Margin
10.69%
13.12%
17.28%
20.87%
17.46%
15.51%
14.24%
Other Income
2.28
2.33
2.46
1.72
0.75
1.94
3.66
Interest
4.29
5.67
3.39
1.94
1.51
0.93
1.38
Depreciation
7.96
7.09
6.37
5.77
2.52
2.50
2.21
PBT
9.45
13.08
17.05
18.09
16.39
17.98
17.52
Tax
3.67
3.58
2.32
3.20
4.26
4.69
5.50
Tax Rate
38.84%
27.37%
13.61%
17.69%
25.99%
26.08%
31.39%
PAT
5.78
9.49
14.73
14.90
12.13
13.29
12.03
PAT before Minority Interest
6.97
9.49
14.73
14.90
12.13
13.29
12.03
Minority Interest
1.19
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
3.18%
5.29%
10.46%
12.91%
10.76%
10.59%
9.81%
PAT Growth
-55.44%
-35.57%
-1.14%
22.84%
-8.73%
10.47%
 
EPS
4.55
7.47
11.60
11.73
9.55
10.46
9.47

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Shareholder's Funds
206.98
193.41
146.47
132.89
121.22
86.63
Share Capital
12.71
12.65
12.22
12.22
12.22
11.70
Total Reserves
194.27
178.16
134.25
120.67
109.00
74.93
Non-Current Liabilities
0.50
0.65
6.04
7.84
3.58
1.42
Secured Loans
1.26
0.87
5.07
6.40
2.36
0.02
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
1.76
1.66
1.46
1.16
1.06
0.98
Current Liabilities
84.56
82.57
72.69
53.27
56.48
48.54
Trade Payables
38.95
47.59
43.30
32.21
37.38
30.57
Other Current Liabilities
11.06
7.28
5.03
4.90
5.91
0.78
Short Term Borrowings
29.56
23.31
19.27
10.93
7.62
11.61
Short Term Provisions
4.99
4.39
5.09
5.23
5.57
5.58
Total Liabilities
292.04
276.63
225.20
194.00
181.28
136.59
Net Block
91.85
92.66
92.48
89.64
33.69
24.38
Gross Block
136.70
130.43
124.26
115.66
57.74
46.58
Accumulated Depreciation
44.85
37.77
31.78
26.02
24.05
22.20
Non Current Assets
125.74
106.22
94.42
91.31
75.11
40.01
Capital Work in Progress
0.00
0.00
0.00
0.00
40.50
14.76
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
1.22
1.11
0.87
0.78
0.63
0.58
Other Non Current Assets
32.67
12.46
1.08
0.90
0.29
0.29
Current Assets
159.59
163.36
123.04
96.03
104.13
96.17
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
59.38
45.06
27.01
5.20
16.96
15.26
Sundry Debtors
55.26
65.26
63.22
52.55
49.96
43.37
Cash & Bank
14.79
20.78
3.82
3.89
3.09
8.52
Other Current Assets
30.18
2.58
20.28
22.95
34.12
29.01
Short Term Loans & Adv.
27.84
29.69
8.69
11.44
12.60
14.41
Net Current Assets
75.04
80.79
50.35
42.76
47.65
47.62
Total Assets
292.03
276.64
225.20
194.00
181.28
136.60

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Cash From Operating Activity
-6.74
-6.29
4.11
12.77
12.80
4.30
PBT
13.08
17.05
18.09
16.39
17.98
17.35
Adjustment
10.77
8.56
7.04
3.43
2.81
2.24
Changes in Working Capital
-27.52
-28.78
-17.82
-2.59
-3.64
-11.29
Cash after chg. in Working capital
-3.68
-3.17
7.31
17.23
17.15
8.30
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-3.06
-3.12
-3.20
-4.46
-4.35
-4.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-5.56
-5.88
-8.47
-17.81
-37.29
-14.76
Net Fixed Assets
-5.74
-5.86
-8.60
-17.42
-36.90
Net Investments
-3.68
-2.02
0.00
0.00
-2.06
Others
3.86
2.00
0.13
-0.39
1.67
Cash from Financing Activity
6.31
29.13
4.30
5.84
19.06
-3.69
Net Cash Inflow / Outflow
-5.99
16.95
-0.07
0.80
-5.43
-14.15
Opening Cash & Equivalents
20.78
3.82
3.89
3.09
8.52
22.66
Closing Cash & Equivalent
14.79
20.78
3.82
3.89
3.09
8.52

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Book Value (Rs.)
157.52
145.25
113.56
103.33
97.55
73.69
ROA
3.34%
5.87%
7.11%
6.46%
8.36%
8.80%
ROE
4.94%
9.13%
11.25%
9.89%
12.94%
13.95%
ROCE
8.46%
10.85%
12.94%
12.99%
16.54%
19.30%
Fixed Asset Turnover
1.34
1.11
0.96
1.30
2.41
2.63
Receivable days
122.66
166.45
183.01
165.97
135.71
129.12
Inventory Days
106.29
93.37
50.92
35.88
46.85
45.43
Payable days
215.82
311.49
316.67
253.69
117.21
106.58
Cash Conversion Cycle
13.14
-51.67
-82.73
-51.84
65.35
67.97
Total Debt/Equity
0.16
0.14
0.19
0.15
0.10
0.14
Interest Cover
3.31
6.03
10.32
11.85
20.30
13.68

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.